Entering the era of living biopharmaceuticals for treating knee osteoarthritis: A systematic review and network meta-analysis

doi:10.4252/wjsc.v17.i8.107076

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

(80)

(61)

(0)

(12)

(3053)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Stem Cells. Aug 26, 2025; 17(8): 107076
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.107076

Full Size Figure Download Figure

Figure 1 Study selection flow diagram (Preferred Reporting Items for Systematic Reviews and Meta-analysis chart). RCT: Randomized controlled trial; MSCs: Mesenchymal stem cells.

Citation: Safwan M, Bourgleh MS, Baroudi L, Almsned A, AlBalawi R, Aibour B, AlFawaz S, Bourgleh SM, Haider KH. Entering the era of living biopharmaceuticals for treating knee osteoarthritis: A systematic review and network meta-analysis. World J Stem Cells 2025; 17(8): 107076
URL: https://www.wjgnet.com/1948-0210/full/v17/i8/107076.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i8.107076

Safwan M, Bourgleh MS, Baroudi L, Almsned A, AlBalawi R, Aibour B, AlFawaz S, Bourgleh SM, Haider KH. Entering the era of living biopharmaceuticals for treating knee osteoarthritis: A systematic review and network meta-analysis. World J Stem Cells 2025; 17(8): 107076 [PMID: 40951711 DOI: 10.4252/wjsc.v17.i8.107076]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.